Disease/Infection News

RSS

Microbiome of young men depends upon circumcision status, patterns of sexual activity

The first study using cultivation independent sequencing of the microorganisms in the adolescent male urinary tract has revealed that the composition of microbial communities colonizing the penis in young men depends upon their circumcision status and patterns of sexual activity.

15 May 2012

U.N., international community should pledge to improve water, sanitation in Haiti to mitigate cholera epidemic

"The cholera epidemic in Haiti, which began in late 2010, is bad and getting worse, for reasons that are well understood and that the aid community has done far too little to resolve," a New York Times editorial states, adding that the "Pan American Health Organization has said the disease could strike 200,000 to 250,000 people this year" and "has already killed more than 7,000."

15 May 2012

Crothall releases new white paper on infection prevention

Leading environmental services provider Crothall Healthcare recently announced the release of its Infection Prevention White Paper, a comprehensive and exhaustively researched document summarizing both the importance of environmental hygiene to a hospital's infection prevention and control (IPC) program and Crothall's integrated environmental services approach to patient safety through reduced transmission of healthcare-associated infections.

15 May 2012

As MDGs set to expire in 2015, U.N. panel to advise on approaches to development; African Progress Panel calls for 'big push' on continent

"The presidents of Indonesia and Liberia -- Susilo Bambang Yudhoyono and Ellen Johnson Sirleaf -- and the prime minister of the United Kingdom, David Cameron, are to co-chair a U.N. panel to advise on approaches to development after the Millennium Development Goals (MDGs) expire in 2015," SciDev.Net reports.

14 May 2012

HIV prevention treatment must include medical, behavorial approaches: APA

A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus, according to the American Psychological Association.

14 May 2012

Excess protein in urine test predicts renal failure in patients with severe sepsis

Henry Ford Hospital researchers have found that the presence of excess protein in a common urine test is an effective prognostic marker of acute renal failure in patients with severe sepsis.

14 May 2012

Energy-efficient LED devices use UV light to kill pathogens

Research from North Carolina State University will allow the development of energy-efficient LED devices that use ultraviolet (UV) light to kill pathogens such as bacteria and viruses. The technology has a wide array of applications ranging from drinking-water treatment to sterilizing surgical tools.

14 May 2012

Groundbreaking biohybrid device to control acute inflammation to prevent sepsis

The body's natural inflammatory response is an essential reaction to injury and infection. When acute inflammation escalates out of control, such as in sepsis, it causes nearly 10% of deaths in the U.S. and more than $17 billion in healthcare costs each year. A group of researchers have developed a groundbreaking biohybrid device that can control acute inflammation to prevent sepsis and other related life-threatening complications, as described in an article in the inaugural issue of Disruptive Science and Technology.

14 May 2012

New Jefferson Hepatitis C Center

Thomas Jefferson University Hospital recently opened its new Jefferson Hepatitis C Center, one of only a few comprehensive, multidisciplinary centers dedicated to the study of hepatitis C virus and hepatic disease in the Pennsylvania, New Jersey and Delaware tri-state area.

14 May 2012

Study reveals variability in physician intentions and recommendations on HPV vaccination

Researchers at Moffitt Cancer Center surveyed 1,008 physicians seeking their knowledge, recommendation beliefs and information on their practices regarding the controversial human papillomavirus (HPV) vaccine, which is aimed at preventing cancers resulting from sexually transmitted HPV infection. Of the physicians surveyed, 112 provided additional comments at the conclusion of the survey.

14 May 2012

JHSPH wins GCE grant for global health and development research project

The Johns Hopkins Bloomberg School of Public Health announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Alain Labrique, PhD, director of the Johns Hopkins University Global mHealth Initiative, will pursue an innovative global health and development research project, titled "mTIKKA - Harnessing a Mobile - Cloud System to Achieve Universal Vaccination."

14 May 2012

FDA ADAC recommends approval of Quad for HIV-1 infection

Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 1 in support of approval of the Quad, a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for the treatment of HIV-1 infection in treatment-naïve adults.

14 May 2012

HIV community supports rapid OTC testing

Who's Positive, a national HIV awareness organization, today announced the results of a year-long online survey measuring support for over-the counter (OTC) HIV testing. The organization will present these results at the upcoming U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) on May 15, 2012.

11 May 2012

Study looking at impact of HIV funding on Rwanda's health system has 'serious limitations'

In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Research Fellow Victoria Fan, Director of Global Health Policy Amanda Glassman, and Research Assistant Rachel Silverman of the Center for Global Development (CGD) examine what they call the "serious limitations" of a study published recently in the American Journal of Tropical Medicine & Hygiene that looked at the impact of HIV/AIDS funding on Rwanda's health system.

11 May 2012

FDA panel recommends approval of Truvada as preventive treatment for HIV

"In a move that could lead to a new milestone for treatment in the evolution of the worldwide AIDS epidemic," a Food and Drug Administration (FDA) panel on Thursday recommended Gilead Sciences' Truvada as a treatment for preventing HIV infection among healthy people at risk of contracting the virus, Reuters reports, noting, "It already has FDA approval to treat people infected with the human immunodeficiency virus".

11 May 2012

Bacteria in digestive tracts compete against invading bacteria

From tiny villages in developing nations to suburban kitchens in the United States, dangerous strains of E. coli bacteria sicken millions of people each year - and kill untold numbers of children.

11 May 2012

HIV prevention drug receives FDA panel's backing

The drug has already been approved as a treatment for HIV/AIDS. The FDA is expected to decide about approval by June 15.

11 May 2012

Safer indoor sex work spaces promote health and safety of street-involved women

Safer indoor sex work spaces provide important and potentially life-saving benefits to sex workers including reduced exposure to violence and HIV and improved relationships with police, according to a study published by the Gender and Sexual Health Initiative of the BC Centre for Excellence in HIV/AIDS (BC-CfE) and the University of British Columbia.

11 May 2012

This Mother's Day, ensure babies everywhere are born free of HIV

Ahead of Mother's Day on May 13, UNAIDS Executive Director Michel Sidibe writes in this post in the Huffington Post's "Global Motherhood" blog, "Together we can go from 390,000 children becoming infected with HIV each year to zero," and he highlights "three simple things we can all do to ensure babies everywhere can be born free from HIV."

11 May 2012

MSF says additional resources needed to improve ART access in Burma

Medecins Sans Frontieres (MSF), the largest provider of antiretroviral treatment (ART) in Burma, also known as Myanmar, are calling for the gap between the need for and access to ART in the country to be closed, the Guardian reports.

11 May 2012